Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 89 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Autologous platelet rich plasma Clear all

Conditions: Vulvar Lichen Sclerosus
Interventions: Autologous Platelet-Rich Plasma (PRP), Sham Procedure; Biological · Other
Lead sponsor: Jennifer R. Arthurs; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Orbital Atrophy
Interventions: autologous fat grafting with PRP to anophthalmic orbits; Procedure
Lead sponsor: Fox, Donald Munro, M.D., P.C.; Individual
Eligibility: 21 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Androgenetic Alopecia
Interventions: Platelet Rich Plasma for 4 sessions, Platelet rich plasma for 2 sessions; Biological
Lead sponsor: Skin Care and Laser Physicians of Beverly Hills; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Osteoarthritis
Interventions: [StroMed + platelet rich plasma (PRP)], [PRP] platelet rich plasma; Biological
Lead sponsor: VivaTech International, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Grove City, Pennsylvania

Conditions: Acute Deep Partial Thickness Thermal Burns
Interventions: Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™); Device
Lead sponsor: Arteriocyte, Inc.; Industry
Eligibility: 18 Years to 86 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 8
States / cities: Phoenix, Arizona • Sacramento, California • Washington D.C., District of Columbia + 5 more

Conditions: Bilateral Primary Osteoarthritis of Knee
Interventions: Autologous Bone Marrow Aspirate Concentrate, Sterile saline; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: COPD, Interstitial Lung Disease
Interventions: Cell therapy; Procedure
Lead sponsor: Lung Institute; Industry
Eligibility: 16 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertrophic Scar
Interventions: PRP Injection, Saline Injection; Biological · Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Femoroacetabular Impingement, Chondral Lesions
Interventions: Platelet-rich plasma (PRP), Saline; Biological · Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Knee Osteoarthritis
Interventions: PRP Treatment, HA Treatment; Biological
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Peyronie Disease, Sexual Dysfunction, Physiological, Sexual Dysfunction Male, Genital Diseases, Male
Interventions: Autologous Platelet-Rich Plasma (PRP), Placebo (Normal Saline); Biological · Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Primary Ovarian Insufficiency, Premature Menopause
Interventions: A-PRP; Procedure
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Platelet-Rich Plasma
Interventions: Autologous platelet rich plasma; Biological
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 95 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Low Back Pain
Interventions: PPP treatment, PRP treatment, PRP and PL Combo treatment; Biological
Lead sponsor: Regenexx, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Broomfield, Colorado • Lone Tree, Colorado

Conditions: Frontal Fibrosing Alopecia
Interventions: Eclipse Easy Spin for PRP; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Arthroscopic Surgery, Triangular Fibrocartilage Complex Injury
Interventions: Platelet-rich Plasma (PRP), Standard Arthroscopic Debridement; Device · Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Plantar Fasciitis
Interventions: platelet rich plasma, corticosteroid injection; Biological · Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Bernadino, California

Conditions: Acute Burns
Interventions: Magellan®, Placebo Saline Gel and Usual and Customary Standard of Care; Device · Other
Lead sponsor: Arteriocyte, Inc.; Industry
Eligibility: 18 Years to 86 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Sacramento, California • Washington D.C., District of Columbia • Salt Lake City, Utah

Conditions: Hip Osteoarthritis
Interventions: Platelet Rich Plasma Joint Injection, Corticosteroid Injection; Device · Drug
Lead sponsor: LifeBridge Health; Other
Eligibility: 21 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Presbylarynx, Atrophy; Larynx, Dysphonia, Vocal Cord Atrophy, Presbylarynges, Vocal Fold Scar, Sulcus Vocalis of Vocal Cord
Interventions: Serial PRP injections; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Osteoarthritis
Interventions: [StroMed + platelet rich plasma (PRP)]; Biological
Lead sponsor: VivaTech International, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Grove City, Pennsylvania

Conditions: Androgenetic Alopecia
Interventions: Autologous Platelet Rich Plasma, Saline solution injection; Device
Lead sponsor: Regen Lab SA; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Los Angeles, California • New York, New York

Conditions: Erectile Dysfunction
Interventions: Autologous Platelet Rich Plasma; Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 65 Years · Male only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Prostate Cancer
Interventions: Autologous Platelet-Rich Plasma, Angel Concentrated Platelet Rich Plasma System; Other · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 50 Years to 60 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets

Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee

Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries

Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis

An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease

Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars

Efficacy of PRP (Platelet Rich Plasma) Following Arthroscopic Microfracture of Chondral Lesions of the Hip

Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis

PRP for Treatment of Peyronie's Disease

Injections of Autologous PRP in Women With Primary Ovarian Insufficiency

Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine

A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain

Platelet Rich Plasma for Frontal Fibrosing Alopecia

Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears

Treatment of Plantar Fasciitis With Platelet Rich Plasma

Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

PRP for the Treatment of Erectile Dysfunction (ED)

Platelet Rich Plasma During Radical Prostatectomy